JP7105916B2 - グリセロール誘導体、これの製造方法及びこれを有効成分として含有する免疫調節剤 - Google Patents
グリセロール誘導体、これの製造方法及びこれを有効成分として含有する免疫調節剤 Download PDFInfo
- Publication number
- JP7105916B2 JP7105916B2 JP2020558931A JP2020558931A JP7105916B2 JP 7105916 B2 JP7105916 B2 JP 7105916B2 JP 2020558931 A JP2020558931 A JP 2020558931A JP 2020558931 A JP2020558931 A JP 2020558931A JP 7105916 B2 JP7105916 B2 JP 7105916B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- glycerol derivative
- formula
- carbon atoms
- palmitoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/38—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
前記化学式3で、R6及びR7はそれぞれ独立して炭素数2乃至18の脂肪酸基であり、R8は-OR9又は-NHR9であり、前記R9は炭素数1乃至3のアルキル基である。具体的に、前記R6及びR7はそれぞれ独立してパルミトイル(Palmitoyl)、リノレオイル(Linoleoyl)等であることができるし、R9はエチル基等であることができる。
Claims (9)
- 下記化学式2又は3で表されるグリセロール誘導体。
[化学式2]
前記化学式2で、R1、R2及びR3の少なくとも一つは-NHR4又は-SR4(ここで、R4はアセチル(Acetyl)、パルミトイル(Palmitoyl)、リノレオイル(Linoleoyl)又はミリストイル(Myristoyl)である)であり、残りは-OC(=O)R5(ここで、R5は炭素数1乃至17の鎖状又は分枝状脂肪族炭化水素基又は炭素数3乃至6の環状脂肪族炭化水素基である)である。
[化学式3]
前記化学式3で、R6及びR7はそれぞれ独立してパルミトイル(Palmitoyl)又はリノレオイル(Linoleoyl)であり、R8は-OR9又は-NHR9(ここで、R9は炭素数1乃至3のアルキル基である)である。 - R 5はメチル(Methyl)、エチル(ethyl)、プロピル(Propyl)、ブチル(Butyl)、ペンタデシル(Pentadexyl)、ヘプタデシル-8,11-ジエン(heptadecyl-8,11-diene)、1-メチルプロピル(1,1-Methylpropyl)、t-ブチル(tert-butyl)、シクロプロピル(cyclopropyl)、シクロヘキシル(cyclohexyl)である、請求項1に記載のグリセロール誘導体。
- R 9はエチル(ethyl)である、請求項1に記載のグリセロール誘導体。
- 下記化学式2又は3で表されるグリセロール誘導体を有効成分として含む免疫調節剤。[化学式2]
前記化学式2で、R1、R2及びR3の少なくとも一つは-NHR4又は-SR4(ここで、R4はアセチル(Acetyl)、パルミトイル(Palmitoyl)、リノレオイル(Linoleoyl)又はミリストイル(Myristoyl)である)であり、残りは-OC(=O)R5(ここで、R5は炭素数1乃至17の鎖状又は分枝状脂肪族炭化水素基又は炭素数3乃至6の環状脂肪族炭化水素基である)である。
[化学式3]
前記化学式3で、R6及びR7はそれぞれ独立してパルミトイル(Palmitoyl)又はリノレオイル(Linoleoyl)であり、R8は-OR9又は-NHR9(ここで、R9は炭素数1乃至3のアルキル基である)である。 - 前記グリセロール誘導体はIL-4、IL-6、及びCXCL8(IL-8)からなる群から選択される一つ以上の炎症サイトカインの過発現を抑制する、請求項4に記載の免疫調節剤。
- 前記グリセロール誘導体はバクテリア又はウイルス感染疾患、急性及び慢性炎症肺疾患、肺炎、自己免疫疾患、アレルギー疾患及び癌からなる群から選択される免疫疾患を予防又は治療する、請求項5に記載の免疫調節剤。
- 前記グリセロール誘導体の含量は0.0001乃至100.0重量%である、請求項6に記載の免疫調節剤。
- 請求項4~7のいずれか一項に記載の免疫調節剤を非ヒト個体に投与する段階を含む、免疫調節方法。
- 下記化学式2又は3で表されるグリセロール誘導体を有効成分として含む免疫調節用健康機能食品組成物。
[化学式2]
前記化学式2で、R1、R2及びR3の少なくとも一つは-NHR4又は-SR4(ここで、R4はアセチル(Acetyl)、パルミトイル(Palmitoyl)、リノレオイル(Linoleoyl)又はミリストイル(Myristoyl)である)であり、残りは-OC(=O)R5(ここで、R5は炭素数1乃至17の鎖状又は分枝状脂肪族炭化水素基又は炭素数3乃至6の環状脂肪族炭化水素基である)である。
[化学式3]
前記化学式3で、R6及びR7はそれぞれ独立してパルミトイル(Palmitoyl)又はリノレオイル(Linoleoyl)であり、R8は-OR9又は-NHR9(ここで、R9は炭素数1乃至3のアルキル基である)である。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180046890A KR102062291B1 (ko) | 2018-04-23 | 2018-04-23 | 글리세롤 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 면역조절제 |
KR10-2018-0046890 | 2018-04-23 | ||
PCT/KR2019/004789 WO2019208980A1 (ko) | 2018-04-23 | 2019-04-19 | 글리세롤 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 면역조절제 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021519807A JP2021519807A (ja) | 2021-08-12 |
JP7105916B2 true JP7105916B2 (ja) | 2022-07-25 |
Family
ID=68293615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020558931A Active JP7105916B2 (ja) | 2018-04-23 | 2019-04-19 | グリセロール誘導体、これの製造方法及びこれを有効成分として含有する免疫調節剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210198183A1 (ja) |
EP (1) | EP3778558A4 (ja) |
JP (1) | JP7105916B2 (ja) |
KR (1) | KR102062291B1 (ja) |
CN (1) | CN112041297B (ja) |
WO (1) | WO2019208980A1 (ja) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004090096A3 (en) | 2002-08-08 | 2005-03-03 | Bresagen Inc | Methods for neural differentiation of embryonic stem cells using protease passaging techniques |
WO2008075983A2 (en) | 2006-12-20 | 2008-06-26 | Industrial Research Limited | Analogues of phosphatidylinositol mannosides |
WO2008113177A1 (en) | 2007-03-20 | 2008-09-25 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
JP2011503050A (ja) | 2007-11-08 | 2011-01-27 | イッサム リサーチ ディべロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム,リミテッド | スフィンゴリピドの新規合成アナログ |
KR20110088991A (ko) | 2010-01-29 | 2011-08-04 | 부산대학교 산학협력단 | 신규 카나비노이드 유도체 및 이의 의학적 용도 |
WO2016086136A1 (en) | 2014-11-26 | 2016-06-02 | Catabasis Pharmaceuticals, Inc. | Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders |
WO2017057540A1 (ja) | 2015-09-30 | 2017-04-06 | 塩野義製薬株式会社 | 免疫賦活活性を有する核酸誘導体 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2820893C2 (de) * | 1978-05-12 | 1986-02-20 | A. Nattermann & Cie GmbH, 5000 Köln | Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen |
DE2820892A1 (de) * | 1978-05-12 | 1979-11-22 | Nattermann A & Cie | Neue strukturanaloga von glyveriden und verfahren zu deren herstellung |
US5059442A (en) * | 1989-09-19 | 1991-10-22 | Nabisco Brands, Inc. | Primary amide esters as low calorie fat mimetics |
US7569706B2 (en) | 2002-09-26 | 2009-08-04 | Kyowa Hakko Kirin Co., Ltd. | Glycerol derivative |
WO2005112912A1 (en) * | 2004-04-24 | 2005-12-01 | Sang-Hee Kim | Immunomoduating agent, anti-cancer agent and health food containing monoacetyldiacylglycerol derivatives |
WO2015026123A1 (ko) | 2013-08-19 | 2015-02-26 | 주식회사 엔지켐생명과학 | 모노아세틸디아실글리세롤 화합물을 유효성분으로 함유하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물 |
-
2018
- 2018-04-23 KR KR1020180046890A patent/KR102062291B1/ko active IP Right Grant
-
2019
- 2019-04-19 EP EP19792728.8A patent/EP3778558A4/en active Pending
- 2019-04-19 WO PCT/KR2019/004789 patent/WO2019208980A1/ko unknown
- 2019-04-19 JP JP2020558931A patent/JP7105916B2/ja active Active
- 2019-04-19 CN CN201980027923.7A patent/CN112041297B/zh active Active
- 2019-04-19 US US17/047,123 patent/US20210198183A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004090096A3 (en) | 2002-08-08 | 2005-03-03 | Bresagen Inc | Methods for neural differentiation of embryonic stem cells using protease passaging techniques |
WO2008075983A2 (en) | 2006-12-20 | 2008-06-26 | Industrial Research Limited | Analogues of phosphatidylinositol mannosides |
WO2008113177A1 (en) | 2007-03-20 | 2008-09-25 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
JP2011503050A (ja) | 2007-11-08 | 2011-01-27 | イッサム リサーチ ディべロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム,リミテッド | スフィンゴリピドの新規合成アナログ |
KR20110088991A (ko) | 2010-01-29 | 2011-08-04 | 부산대학교 산학협력단 | 신규 카나비노이드 유도체 및 이의 의학적 용도 |
WO2016086136A1 (en) | 2014-11-26 | 2016-06-02 | Catabasis Pharmaceuticals, Inc. | Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders |
WO2017057540A1 (ja) | 2015-09-30 | 2017-04-06 | 塩野義製薬株式会社 | 免疫賦活活性を有する核酸誘導体 |
Non-Patent Citations (4)
Title |
---|
Angewandte Chemie,International Edition,2011年,50(31),7052-7055 |
Biochemical Society Transactions,1988年,16(3),293 |
European Journal of Organic Chemistry,2009年,(9),1313-1316 |
Journal fuer Praktische Chemie/Chemiker-Zeitung,1993年,335(7),628-632 |
Also Published As
Publication number | Publication date |
---|---|
EP3778558A1 (en) | 2021-02-17 |
CN112041297A (zh) | 2020-12-04 |
KR102062291B1 (ko) | 2020-01-03 |
JP2021519807A (ja) | 2021-08-12 |
US20210198183A1 (en) | 2021-07-01 |
EP3778558A4 (en) | 2022-08-10 |
WO2019208980A1 (ko) | 2019-10-31 |
CN112041297B (zh) | 2023-10-20 |
KR20190123123A (ko) | 2019-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5936076A (en) | αgalactosylceramide derivatives | |
US11510980B2 (en) | Brartemicin analogues | |
JP7162676B2 (ja) | 1,2-ジアシルグリセロール化合物、その製造方法及びこれを有効成分として含有する免疫調節剤 | |
JP7060500B2 (ja) | 薬学的組成物の製造方法、医薬部外品組成物の製造方法、飼料組成物の製造方法、及び、飲用水添加剤の製造方法 | |
KR101710474B1 (ko) | 갈아마이드 유도체 및 이의 용도 | |
JP6976014B1 (ja) | 新規ポリフェノール化合物 | |
JP7105916B2 (ja) | グリセロール誘導体、これの製造方法及びこれを有効成分として含有する免疫調節剤 | |
KR100570936B1 (ko) | 시클로펜텐 고리 또는 시클로펜탄 고리를 갖는 화합물 | |
KR101927209B1 (ko) | 멜라토닌 유도체를 포함하는 염증성 질환, 알러지 질환 또는 암 질환 예방 또는 치료용 조성물 | |
JP2008106008A (ja) | ゲニポシド酸誘導体 | |
JPWO2016195017A1 (ja) | 10−ヒドロキシ−シス−12−オクタデセン酸アルキルエステル及びその用途 | |
JP6923100B1 (ja) | 新規イソフラボン化合物 | |
JP7050174B2 (ja) | ジアシルグリセロールラクトン化合物、その製造方法及びこれを有効成分として含有する免疫増進剤 | |
CN110198950B (zh) | 新的麦角甾烯醇糖苷衍生物 | |
JP6368270B2 (ja) | モニエロサイドa及びその誘導体、又はそれを有効成分として含有する医薬用組成物、健康食品又は化粧品 | |
JP2013043885A (ja) | デヒドロアミノ酸含有グリセロール誘導体 | |
JP2019531275A (ja) | 脱水素アビエチン酸及びコンパウンドkを含む皮膚抗老化用組成物 | |
KR20210146333A (ko) | 면역부활제 및 면역부활용 음식물 | |
JP2024509902A (ja) | アミノ酸誘導体、その製造方法及びそれを含む肝炎治療用薬学的組成物 | |
KR20210053622A (ko) | 카페익산 에스테르 유도체를 유효성분으로 함유하는 아토피 피부염 예방 또는 치료용 조성물 및 이의 합성방법 | |
JP2012031081A (ja) | 抗アレルギー剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201022 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211124 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220215 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220621 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220712 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7105916 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |